NCT00193102View on ClinicalTrials.gov

Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

February 28, 2005

Study Completion Date

June 30, 2010

Conditions

Breast Cancer

Interventions

DRUG

Thalidomide

Thalidomide

DRUG

Capecitabine

Capecitabine

Sponsors

Collaborators (1)

Celgene Corporation

All Listed Sponsors

collaborator

Celgene Corporation

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER